Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China
Importance Dyslipidemia, the prevalence of which historically has been low in China, is
emerging as the second leading yet often unaddressed factor associated with the risk of …
emerging as the second leading yet often unaddressed factor associated with the risk of …
Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: A cross-sectional study
L Xing, L Jing, Y Tian, H Yan, B Zhang, Q Sun… - Nutrition, Metabolism …, 2020 - Elsevier
Background and aims Management of dyslipidemia remains the cornerstone for prevention
of cardiovascular diseases. We aimed to evaluate the epidemiology of dyslipidemia in …
of cardiovascular diseases. We aimed to evaluate the epidemiology of dyslipidemia in …
Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults
M Zhang, Q Deng, L Wang, Z Huang, M Zhou… - International journal of …, 2018 - Elsevier
Background Elevated serum total cholesterol and low-density lipoprotein cholesterol (LDL-
C) levels are established risk factors for cardiovascular diseases, a leading cause of death …
C) levels are established risk factors for cardiovascular diseases, a leading cause of death …
[HTML][HTML] Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control
Y Huang, L Gao, X Xie, SC Tan - Population health metrics, 2014 - Springer
Background Numerous epidemiology studies on dyslipidemia have been conducted in
China. However, a nationally representative estimate for dyslipidemia prevalence is lacking …
China. However, a nationally representative estimate for dyslipidemia prevalence is lacking …
[HTML][HTML] The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey
FL Zhang, YQ Xing, YH Wu, HY Liu, Y Luo… - Lipids in health and …, 2017 - Springer
Background Dyslipidemia is an important independent modifiable risk factor for
cardiovascular disease. The aim of this study was to explore the current prevalence …
cardiovascular disease. The aim of this study was to explore the current prevalence …
[HTML][HTML] Awareness, treatment, control, and determinants of dyslipidemia among adults in China
Effective management of dyslipidemia is important. This study aimed to determine the
awareness, treatment, control, and determinants of dyslipidemia in middle-aged and older …
awareness, treatment, control, and determinants of dyslipidemia in middle-aged and older …
Dyslipidemia prevalence, treatment, control, and awareness in the Canadian Health Measures Survey
M Joffres, M Shields, MS Tremblay… - Canadian journal of public …, 2013 - Springer
Abstract Background The most recent Canadian population-level data on lipid levels are
from 1992. This study presents current estimates of Canadians with dyslipidemia, the …
from 1992. This study presents current estimates of Canadians with dyslipidemia, the …
[HTML][HTML] Prevalence and associated factors of dyslipidemia in the adult Chinese population
To determine the prevalence, associated factors, awareness and control of dyslipidemia in
Chinese living in Greater Beijing, we measured the serum cholesterol concentration in 3251 …
Chinese living in Greater Beijing, we measured the serum cholesterol concentration in 3251 …
[HTML][HTML] Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project …
Background Dyslipidemia is a modifiable risk factor for cardiovascular disease (CVD). We
investigated the prevalence and associated risk factors of dyslipidemia-raised total …
investigated the prevalence and associated risk factors of dyslipidemia-raised total …
Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US …
Background The 2013 American College of Cardiology/American Heart Association
Cholesterol Management Guideline identifies 4 statin-eligible groups:(1) known …
Cholesterol Management Guideline identifies 4 statin-eligible groups:(1) known …